1-3 of 3
Won Seog Kim, M.D.
Close
Sort by
Journal Articles

Excessive Toxicity of Once Daily Intravenous Busulfan, Melphalan, and Thiotepa Followed by Autologous Stem Cell Transplantation On Patients with Non-Hodgkin's Lymphoma.

Jong-Ho Won, M.D., Ph.D., Sang-Cheol Lee, M.D., Seok Jin Kim, M.D., Ph.D., Dae Ho Lee, M.D., Ph.D., Won Seog Kim, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Hee-Sook Park, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 4361.
https://doi.org/10.1182/blood.V114.22.4361.4361
Published: 2009
Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 3446.
https://doi.org/10.1182/blood.V110.11.3446.3446
Published: 2007
Journal Articles

CHOP Followed by Radiotherapy for Localized Aggressive Primary Gastric Lymphoma: Results of a Multi Center Phase II Study.

Yeon Hee Park, M.D., Won Seog Kim, M.D., Baek-Yeol Ryoo, M.D., Sung Hyun Yang, M.D., Mi Sook Kim, M.D., Seung-Sook Lee, M.D., Kihyun Kim, M.D., Keon Woo Park, M.D., Chul W. Jung, M.D., Yong Chan Ahn, M.D., Do Hoon Lim, M.D., Young H. Ko, M.D., Keunchil Park, M.D.
Journal: Blood
Blood (2004) 104 (11): 3306.
https://doi.org/10.1182/blood.V104.11.3306.3306
Published: 2004